Inventiva IVA
NASDAQ IVA
$4.78 -0.06 (-1.24%)
As of: Sep 4, 2026 · 3:59 PM EDT

Inventiva (IVA) Depreciation & Amortization (CF) (2019 - 2022)

Inventiva (IVA) posted quarterly Depreciation & Amortization (CF) of -$4.4 million for Q2 2025, down 17.5% year-over-year from -$5.4 million in Q2 2024, and down 6.17% quarter-over-quarter from -$4.2 million in Q4 2024.

Analysis

Inventiva (IVA) Depreciation & Amortization (CF) (2019 - 2022) Analysis & Trends

Inventiva's Depreciation & Amortization (CF) history runs 7 years deep, the most recent figure standing at -$4.4 million for Q2 2025.

  • In Q2 2025, Depreciation & Amortization (CF) fell 17.5% year-over-year to -$4.4 million; the TTM figure through Dec 2025 stood at $1.3 million (up 131.45% YoY), while the FY2024 annual figure was -$4.2 million, down 14.43% from the prior year.
  • Depreciation & Amortization (CF) for Q2 2025 stood at -$4.4 million, down from -$4.2 million in the prior quarter.
  • The five-year high for Depreciation & Amortization (CF) was $662584.1 in Q3 2022, with the low at -$4.4 million in Q2 2025.
  • The 5-year median for Depreciation & Amortization (CF) is -$1.6 million (2021), against an average of -$1.7 million.
  • The sharpest annual moves came in 2022 and 2023: Depreciation & Amortization (CF) gained 6.05% in 2022, then sank 662.0% in 2023.
  • Inventiva's Depreciation & Amortization (CF) stood at $610880.5 in 2021, then increased by 6.05% to $647857.1 in 2022, then slumped by 662.0% to -$3.6 million in 2023, then dropped by 14.43% to -$4.2 million in 2024, then slipped by 6.17% to -$4.4 million in 2025.
  • Business Quant data shows IVA's Depreciation & Amortization (CF) at -$4.4 million in Q2 2025, -$4.2 million in Q4 2024, and -$3.8 million in Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 56.50 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 123.70 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 40.52 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Inventiva 893.85 Mn 893.85 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 647,857.08
Sep 22, 2022 662,584.15
Dec 31, 2021 610,880.49
Jun 30, 2021 276,982.43
Mar 31, 2021 366,695.78
Dec 31, 2020 795,257.33
Jun 30, 2020 363,481.84
Mar 31, 2020 372,027.45
Dec 31, 2019 649,743.06